LARGE B-CELL LYMPHOMA (LBCL)
Clinical trials for LARGE B-CELL LYMPHOMA (LBCL) explained in plain language.
Never miss a new study
Get alerted when new LARGE B-CELL LYMPHOMA (LBCL) trials appear
Sign up with your email to follow new studies for LARGE B-CELL LYMPHOMA (LBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental CAR-T therapy targets Hard-to-Treat lymphoma
Disease control Not yet recruitingThis early-phase study tests a new type of CAR-T cell therapy (CD19X) in 3 people with large B-cell lymphoma that has returned or not responded to standard treatment. The main goal is to check safety, looking for side effects like immune reactions or nerve problems. Researchers w…
Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 11:27 UTC
-
New Triple-Drug cocktail aims to beat back tough lymphoma
Disease control Not yet recruitingThis early-stage trial tests a new combination of three drugs (golcadomide, poseltinib, and rituximab) for adults with relapsed or refractory large B-cell lymphoma, a type of blood cancer. The study aims to see if this combination can shrink tumors in more than 30% of the 20 part…
Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated May 20, 2026 11:56 UTC